Spironolactone Tablet, Film Coated
Product Images NDC 63187-861

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 63187-861). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spironolactone Structure (01)

Spironolactone Structure (01)
Chemical structure of spironolactone, showing its steroid nucleus with attached functional groups including a lactone ring and a thioacetate moiety.*
FDA Label Image

63187-861-30 (50mg)

63187-861-30 (50mg)
Label for Spironolactone 50 mg tablets, film-coated, round and biconvex, debossed with 'TL 217' on one side and scored on the other. Pack contains 30 tablets. Manufactured by Jubilant Generics Limited, India, and packaged by Proficient Rx LP, Thousand Oaks, CA. Storage instructions: 20°-25°C (68°-77°F). Includes NDC 63187-861-30 and directions to keep medication out of reach of children.*
FDA Label Image

Figure 2 (Fig 2)

Figure 2 (Fig 2)
A line graph showing probability over time in months, comparing two groups: one receiving Spironolactone and one receiving placebo. The graph includes survival curves for both groups, with sample sizes indicated (Spironolactone n=822, Placebo n=841). A log-rank p-value of less than 0.001 is noted, indicating statistical analysis of the difference between the groups.*
FDA Label Image

Figure 3 (Fig 3)

Figure 3 (Fig 3)
A forest plot showing hazard ratios (HR) and 95% confidence intervals (CI) for various subgroups related to Spironolactone versus placebo outcomes. Subgroups include age, sex, race, LVEF percentage, heart failure type, NYHA class, diabetes status, serum creatinine levels, creatinine clearance, potassium levels, digoxin use, ACEI use, and beta blocker use, with sample sizes indicated for each subgroup.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.